{"file_date_updated":"2020-11-25T09:43:40Z","year":"2020","publication_status":"published","pmid":1,"page":"608-621","file":[{"access_level":"open_access","relation":"main_file","file_id":"8805","file_size":1439550,"success":1,"creator":"dernst","content_type":"application/pdf","checksum":"67db0251b1d415ae59005f876fcf9e34","file_name":"2020_TrendsNeuroscience_Parenti.pdf","date_created":"2020-11-25T09:43:40Z","date_updated":"2020-11-25T09:43:40Z"}],"tmp":{"short":"CC BY (4.0)","image":"/images/cc_by.png","name":"Creative Commons Attribution 4.0 International Public License (CC-BY 4.0)","legal_code_url":"https://creativecommons.org/licenses/by/4.0/legalcode"},"day":"01","external_id":{"isi":["000553090600008"],"pmid":["32507511"]},"doi":"10.1016/j.tins.2020.05.004","publication":"Trends in Neurosciences","user_id":"4359f0d1-fa6c-11eb-b949-802e58b17ae8","scopus_import":"1","oa_version":"Published Version","citation":{"short":"I. Parenti, L.E. Garcia Rabaneda, H. Schön, G. Novarino, Trends in Neurosciences 43 (2020) 608–621.","mla":"Parenti, Ilaria, et al. “Neurodevelopmental Disorders: From Genetics to Functional Pathways.” Trends in Neurosciences, vol. 43, no. 8, Elsevier, 2020, pp. 608–21, doi:10.1016/j.tins.2020.05.004.","chicago":"Parenti, Ilaria, Luis E Garcia Rabaneda, Hanna Schön, and Gaia Novarino. “Neurodevelopmental Disorders: From Genetics to Functional Pathways.” Trends in Neurosciences. Elsevier, 2020. https://doi.org/10.1016/j.tins.2020.05.004.","ista":"Parenti I, Garcia Rabaneda LE, Schön H, Novarino G. 2020. Neurodevelopmental disorders: From genetics to functional pathways. Trends in Neurosciences. 43(8), 608–621.","ama":"Parenti I, Garcia Rabaneda LE, Schön H, Novarino G. Neurodevelopmental disorders: From genetics to functional pathways. Trends in Neurosciences. 2020;43(8):608-621. doi:10.1016/j.tins.2020.05.004","apa":"Parenti, I., Garcia Rabaneda, L. E., Schön, H., & Novarino, G. (2020). Neurodevelopmental disorders: From genetics to functional pathways. Trends in Neurosciences. Elsevier. https://doi.org/10.1016/j.tins.2020.05.004","ieee":"I. Parenti, L. E. Garcia Rabaneda, H. Schön, and G. Novarino, “Neurodevelopmental disorders: From genetics to functional pathways,” Trends in Neurosciences, vol. 43, no. 8. Elsevier, pp. 608–621, 2020."},"project":[{"_id":"25444568-B435-11E9-9278-68D0E5697425","name":"Probing the Reversibility of Autism Spectrum Disorders by Employing in vivo and in vitro Models","grant_number":"715508","call_identifier":"H2020"}],"acknowledgement":"We wish to thank Jasmin Morandell for generously sharing Figure 2. This work was supported by the European Research Council Starting Grant (grant 715508 ) to G.N.","isi":1,"_id":"7957","date_published":"2020-08-01T00:00:00Z","article_type":"original","author":[{"id":"D93538B0-5B71-11E9-AC62-02EBE5697425","first_name":"Ilaria","full_name":"Parenti, Ilaria","last_name":"Parenti"},{"last_name":"Garcia Rabaneda","full_name":"Garcia Rabaneda, Luis E","first_name":"Luis E","id":"33D1B084-F248-11E8-B48F-1D18A9856A87"},{"id":"C8E17EDC-D7AA-11E9-B7B7-45ECE5697425","first_name":"Hanna","full_name":"Schön, Hanna","last_name":"Schön"},{"id":"3E57A680-F248-11E8-B48F-1D18A9856A87","first_name":"Gaia","full_name":"Novarino, Gaia","orcid":"0000-0002-7673-7178","last_name":"Novarino"}],"has_accepted_license":"1","publication_identifier":{"issn":["01662236"],"eissn":["1878108X"]},"volume":43,"date_updated":"2024-10-09T20:59:38Z","date_created":"2020-06-14T22:00:49Z","month":"08","publisher":"Elsevier","article_processing_charge":"No","ddc":["570"],"ec_funded":1,"quality_controlled":"1","type":"journal_article","oa":1,"language":[{"iso":"eng"}],"department":[{"_id":"GaNo"}],"corr_author":"1","issue":"8","intvolume":" 43","status":"public","title":"Neurodevelopmental disorders: From genetics to functional pathways","abstract":[{"lang":"eng","text":"Neurodevelopmental disorders (NDDs) are a class of disorders affecting brain development and function and are characterized by wide genetic and clinical variability. In this review, we discuss the multiple factors that influence the clinical presentation of NDDs, with particular attention to gene vulnerability, mutational load, and the two-hit model. Despite the complex architecture of\r\nmutational events associated with NDDs, the various proteins involved appear to converge on common pathways, such as synaptic plasticity/function, chromatin remodelers and the mammalian target of rapamycin (mTOR) pathway. A thorough understanding of the mechanisms behind these pathways will hopefully lead to the identification of candidates that could be targeted for treatment approaches."}]}